Canada: Cannabis Legalization One Step Closer With Regulations Finalized

Canada has now, for the most part, arrived at legalization. Canada's Cannabis Act (Act) received Royal Assent on June 21 and the Regulations under that Act (Regulations) are being published in final form—without opportunity for comment—on July 11.1 Other than the October 17 "coming into force" date for the Act and the Regulations, Canada has arrived at legalization for recreational use of cannabis.

What You Need To Know

  • The Regulations establish the rules and standards on production, distribution, sale, importation, and exportation of cannabis for recreational use by licence holders.
  • For the most part, the Regulations are consistent with the federal government's proposed cannabis regulatory framework that was released on November 21, 2017.
  • Health Canada will require reporting of investments in cannabis companies, and will provide guidance on when reporting requirements are triggered.
  • Security clearance must be obtained for any individual, or director or officer, who exercises, or is in a position to exercise, direct control over a corporation that holds a licence for cultivation, processing or sale.
  • Import and export of cannabis is limited to import or export for medical or scientific purposes and requires a certificate.
  • Some additional framework provided by Health Canada include classification and types of cannabis products, regulatory oversight, outdoor cultivation, pesticides and microbial contaminants, and packaging and labelling.

The Details

In further detail, the key aspects of the federal government's cannabis regulatory framework are listed below.

Law and Timing

The Cannabis Act received Royal Assent on June 21 and is now law.2 The Regulations will become law on July 11, when published in the Canada Gazette, Part II. Together, the Cannabis Act and the Regulations will come into force on October 17. The Regulations include:

  • Cannabis Regulations
  • The new Industrial Hemp Regulations
  • Qualifications for Designation as Analyst Regulations (Cannabis)
  • Cannabis Act (Police Enforcement) Regulations

Until October 17, cannabis will continue to be regulated under the Controlled Drugs and Substances Act, Access to Cannabis for Medical Purposes Regulations (ACMPR) and Industrial Hemp Regulations.

Licensed producers under the ACMPR and Industrial Hemp Regulations may continue to possess, sell or conduct other activities with cannabis, as indicated in their licence.3 Licensed producers will be known as license holders under the Regulations.4

Other authorized activities include shipping and transporting of cannabis products5 to designated retailers6 in preparation for the public sale of cannabis for recreational use.7 However retailers will not be permitted to sell cannabis for recreational use until October 17.

The ACMPR and the current Industrial Hemp Regulations will be repealed on October 17. The Regulations contain provisions that will apply to the sale of cannabis for medical use under a physician's authorization and, as such, the Regulations will address the sale of cannabis for recreational use and for medical use.

Classification and Regulatory Pathways

The Cannabis Act and Regulations apply to "cannabis products," including fresh and dried cannabis, cannabis oil, and cannabis plants or seeds, or a cannabis accessory if that accessory contains such forms of cannabis.

A cannabis product excludes a drug containing cannabis as an active pharmaceutical ingredient, 8 or a drug that is manufactured or sold for use in a clinical trial. 9 Drugs containing cannabis will be reviewed, approved, and regulated through Health Canada's current drug regulatory pathways. Drugs containing cannabis must be issued a drug identification number (DIN) 10 before they can be sold. Cannabis products that make therapeutic claims are also classified as drugs containing cannabis. 11

Natural Health Products (NHP) containing cannabis will be reviewed, approved, and regulated under the Natural Health Products Regulations. The interface between "drugs containing cannabis" and NHPs containing cannabis is not entirely clear. An NHP containing cannabis must not include more than 10 ug/g THC, an isolated or concentrate phytocannabinoid or a synthetic duplicate of that phytocannabinoid.

Industrial hemp is cannabis that contains 0.3% tetrahydrocannabinol (THC) or less in the flowering heads and leaves, and is regulated under the Industrial Hemp Regulations.

Foods and cosmetics containing hemp will be regulated by the food regulatory and cosmetic regulatory pathways.12

Edibles and Concentrates

Edibles that only contains derivatives of cannabis (e.g., hemp) will be regulated as a food under the Food and Drugs Act and edibles containing cannabis (i.e., higher than 10 ug/g THC) will be regulated under the Regulations. For both edibles containing cannabis and for concentrates, an amendment to Schedule 4 to the Act—which sets out the classes of cannabis, which are currently plants, seeds, fresh, dried, oil—will be required. The Regulations will also need to be amended.

The proposed approach to regulation of cannabis provides that the "edibles containing cannabis" class would include edible products, such as foods or beverages that contain cannabis, and that a precise definition would be set out in a subsequent regulatory proposal.

Import and Export

With a permit, cannabis may be imported or exported, but only for medical or scientific purposes. The Regulations do not impose limits on the amount of cannabis that may be imported or exported. However, each application for an import or export permit must specify the quantity of cannabis to be imported or exported under that permit.

Types of Cannabis Products

As of October 17, the types of cannabis products authorized for sale for recreational use will be fresh and dried cannabis, cannabis oil, and cannabis plants or seeds, or a cannabis accessory if that accessory contains such forms of cannabis.

  • The maximum limits on yield quantity or cannabis products are listed below.
    • Each discrete unit of a cannabis product intended to be taken by a user must not exceed a maximum yield quantity of 10 mg of THC.
    • Dried cannabis in each discrete unit of a cannabis product intended to be inhaled by a user must not exceed 1.0 g.
    • Cannabis oil must not exceed a maximum yield quantity of 30 mg of THC.
    • There is no THC limit for dried cannabis.
    • For determining compliance to the limits on personal use of cannabis, one cannabis plant will be considered equivalent to three cannabis seeds.

Methods of administration of cannabis contemplated by the Regulations include administration through oral, rectal, vaginal, topical routes. However cannabis products intended to be used in the human eye, or administered by disrupting the skin barrier are prohibited.

Cannabis accessories are also regulated by the Regulations.13 Some regulatory requirements include:

  • THC or THCA cannot be added to dried or fresh cannabis that will become a cannabis product, or that will be contained in a cannabis accessory that will become a cannabis product.
  • For cannabis oil, any accessory that dispenses cannabis oil, and is packaged with cannabis oil or a cannabis accessory that contains the oil, that is intended to be ingested, must not dispense more than 10 mg of THC.
  • A cannabis accessory must not impart a characterizing flavour to the cannabis.
  • A cannabis accessory packaged with the cannabis product must not alter or enhance the effects of the phytocannabinoids.14
  • Same packaging and labelling requirements that applies to cannabis products applies to cannabis accessories.
  • A licence holder must maintain a list of the names and types of cannabis accessories that they sell and must retain each version of the list for at least two years after being replaced by a new version, or at least two years after the licence expires or is revoked.

For every new cannabis product that has not previously been sold in Canada, a notice must be provided to Health Canada 60 days before the sale date. Information in the notice should include:

  • the class of cannabis under the Act, to which the cannabis product belongs;
  • a description of the cannabis product, including the brand name; and
  • the date on which the cannabis product is expected to be made available for sale.

Regulatory Oversight

The regulator which oversees the application of the Act and Regulations is Health Canada.

The different classes of licences available under the Regulations include cultivation (micro, standard, nursery), processing (micro, standard), analytical testing, sale, research, and a cannabis drug licence. There is no limit on how many licences an individual or a corporation may hold. A licence issued under the ACMPR is deemed to be a licence for cultivation, processing, or sale, and a subclass of licences if requirements are met.15

An individual, corporation, partnership or a cooperative can hold a licence to cultivate, process, sell, perform analytical testing and research on cannabis. The entities may also hold a cannabis drug licence.

The overall regulatory scheme for licence holders is similar to that of other regulated products, such as foods, drugs, medical devices and natural health products, but with more emphasis on security of the site, security clearances and maintaining and reporting ownership interests and investors to Health Canada. For example, as for other regulated products:

  • Health Canada may require a document or information be provided on an urgent basis, if there is an issue of public health or public safety;
  • a licence holder must notify Health Canada before commencing a voluntary recall of a cannabis product; and.
  • Health Canada can suspend a licence for failure to hold the necessary security clearance, failure to pay necessary fees, and for incompliance with the Excise Act, 2001.

The Regulations expressly state a patient's medical document may be transferred to another licence holder if requested by the patient—this concept was not expressed in the ACMPR.

Outdoor Cultivation, Pesticides and Microbial Contaminants

Cannabis may be cultivated indoors or outdoors so long as physical security requirements have been met. However it's important to note that as provinces and territories have the ability to create additional rules on the regulation of cannabis for recreational use, municipal zoning bylaws will provide guidelines on how they intend to manage indoor and outdoor cultivation and whether they intend to prohibit outdoor cultivation.

Outdoor cultivation of cannabis does not require additional security measures from indoor cultivation.

Only pesticides approved under the Pest Control Products Act may be used to treat cannabis, and the pesticides must not exceed any maximum residue limit, in relation to cannabis, specified for a particular pest control product.

Cannabis products may contain microbial or chemical contaminants if they are within tolerance limits for herbal medicines for human consumption, referred to in Schedule B to the Food and Drugs Act.

Security Clearance

For a corporation that holds a licence for cultivation, processing and sale of cannabis, security clearance is required for the following individuals.

  • All directors and officers.
  • Any individual, director or officer of any corporation, who exercises, or is in a position to exercise, direct control over the corporation.
  • Any individual, director or officer of any corporation, that is a partner in a partnership that exercises, or is in a position to exercise, direct control over the corporation.

Security clearance for the person responsible, head of security, master grower, quality assurance person, and alternates of each of the preceding positions is required, as applicable.

There are a number of factors considered in granting security clearance, including whether an applicant poses a risk to public health or public safety, and whether there is a risk of cannabis being diverted to an illicit market or for an illicit activity. A person with a previous conviction will not automatically be excluded from obtaining a security clearance as Health Canada will make these assessments on case-by-case basis. If security clearance is refused or suspended, an applicant may appeal within 20 days and may reapply in five years (or sooner, if circumstances change).

By January 17, 2019, all individuals associated with a licence holder required to hold a security clearance under the Act must have submitted an application.

Key Investors

Licence holders must maintain a record of key investors and provide a report to Health Canada on an annual basis. A key investor is a person who exercises, or is in a position to exercise, direct or indirect control over the licence holder. Health Canada will provide guidance on determining the type of investor who would trigger the reporting requirement.

A licence holder's records must include transactions involving money, goods and services, benefits received as a result, and whether the ownership interest, or other right or interest held by the key investor has been assigned, pledged, hypothecated or sold.

For licences issued under the ACMPR, the licence holder is not required to provide information on transactions involving a key investor that occur before October 17.

Packaging and Labelling

The packaging and labelling requirements mirror the details set out in the consultation paper on the Proposed Approach to the Regulation of Cannabis.16 The packaging and labelling requirements are prescriptive with little flexibility provided.

Licence holders authorized under the ACMPR must comply with packaging and labelling requirements under the Regulations by April 17, 2019.

Informational Promotion and Brand Preference Promotion

Similar to packaging and labelling, the ways in which cannabis companies can promote themselves are prescriptive. Under the Cannabis Act, licence holders may promote cannabis products and cannabis accessories by informational promotion17 and brand preference promotion. However, they may only do so if the promotion is in a communication addressed and sent to an adult and is identified by name, in a place where young persons are not permitted by law, or communicated by means of telecommunication, in a prescribed place and done in a prescribed manner.18

Licence holders authorized to sell cannabis or a cannabis accessory may promote it at the point of sale if the promotion only indicates its availability and/or its price.

Licence holders are prohibited from promoting cannabis, a cannabis accessory or any service related to cannabis by means of a testimonial or endorsement. They're also prohibited from depicting a person, character or animal, whether real or fictional, or by presenting it or any of its brand elements in a manner that associates it or the brand element with glamour, recreation, excitement, vitality, risk or daring.19

Licence holders are also prohibited from sponsoring a person, entity, event, activity or facility, if the facility is used for a sports or cultural event or activity. 20

Reasonable steps must also be taken by the licence holders to ensure the promotion cannot be accessed by a young person. However, cannabis products and cannabis accessories may be promoted by informational promotion and brand-preference promotion to young persons for medical reasons. Each year, licence holders must provide the total amount of money spent in a given calendar year to Health Canada on promotion a) directed at consumers who purchase cannabis at the retail level; and b) directed at consumers who do not purchase cannabis at the retail level. Description of the types of promotion must also be included.

No product inserts or leaflets may be included in a container in which a cannabis product is packaged.

What's Next?

The Regulations will be published in the Canada Gazette, Part II, on July 11. Together with the Cannabis Act, the Regulations will come into force on October 17.

Torys lawyers have written extensively on cannabis. You can view the team's thought leadership by heading to the Emerging Trends in the Cannabis Industry page.

Footnotes

1 While Regulations will be published in final form on July 11, an advance copy of the Regulations is available. The Regulations accord, for the most part, with the Government's publication of its proposed cannabis regulatory framework. See "Government of Canada Releases Proposed Cannabis Regulatory Framework."

2 The last step in the process is the date that the Act and Regulations "come into force." That date is October 17.

3 Cannabis Act, s. 160.1.

4 Under the ACMPR, the term "licensed producer" was used for those who held a licence under s 35 of the ACMPR. However, the Regulations refer to holders of a licence, rather than licensed producers.

5 Including fresh marihuana, dried marihuana, cannabis oil and marihuana plants or seeds that are cannabis and that are indicated, and authorized in their licence issued under section 35 of the ACMPR.

6 Every province or territory has the authority to determine the retail framework in their own province or territory.

7 However, provincial/territorial authorizations is required in order to possess, sell, provide, send, deliver or transport cannabis or offer to perform any of those activities. See Cannabis Act, s. 160.1(5).

8 As defined in Food and Drug Regulations, C.01A.001(1).

9 As defined in Food and Drug Regulations, C.05.001.

10 Pursuant to Food and Drug Regulations, C.01.014.2(1).

11 Therapeutic claims arise when products are represented for use in the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or its symptoms, in human beings; or restoring, correcting or modifying organic functions in human beings.

12 Food and Drugs Regulations, and Cosmetics Regulations.

13 Defined in the Cannabis Act as a) a thing, including rolling papers or wraps, holders, pipes, water pipes, bongs and vaporizers, that is represented to be used in the consumption of cannabis; or b) a thing that is deemed to be represented to be used in the consumption of cannabis.

14 Same prohibition applies to any component of a cannabis product.

15 Subclass of licences include licence for standard, or micro, cultivation or processing, nursery, or sale for medical purposes.

16 See "Government of Canada Releases Proposed Cannabis Regulatory Framework" and "A Flower by Any Other Name: Cannabis Trademarks and Branding."

17 Cannabis Act, s. 2. Informational promotion means a promotion by which factual information is provided to the consumer about a) cannabis or its characteristics; b) a cannabis accessory or its characteristics; c) a service related to cannabis; or d) the availability or price of cannabis, a cannabis accessory or a service related to cannabis. Brand preference promotion means promotion of cannabis by means of its brand characteristics, promotion of a cannabis accessory by means of its brand characteristics or promotion of a service related to cannabis by means of the brand characteristics of the service.

18 See Cannabis Act, s. 17.

19 See ibid.

20 Sponsorship includes displaying, referring to a brand element of cannabis, or cannabis accessory or a service related to cannabis; and the name of the person that produces, sells or distributes cannabis, sells or distributes a cannabis accessory, or provides a service related to cannabis. See Cannabis Act, s. 21-22.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Norton Rose Fulbright Canada LLP
Stewart McKelvey
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Norton Rose Fulbright Canada LLP
Stewart McKelvey
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions